SLI Medical Acceptable Dating: we will ship >= 90 days
Storage Requirements
Requires Refrigeration
Strength
100 mg / mL
Type
Subcutaneous
UNSPSC Code
51202400
Volume
1 mL
Features
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of patients with severe asthma aged 6 years and older
and with an eosinophilic phenotype.
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non hematologic secondary cause.
Requires Refrigeration
